TrialThe Lancet. Oncology2016

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.

Neyssa M Marina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.